Most patients with emergency department visit for nonfatal opioid overdose were men; most frequent drugs reported were fentanyl and heroin
Extended-release injection available in lower doses to be administered in health care settings by health care providers
Methadone dispensing up after 2020 without displacing use of buprenorphine
More White than Black and Hispanic patients receive buprenorphine, naloxone, benzodiazepines in 180 days after index event
Persons receiving medication for opioid use disorder more likely to be older, White and to have public insurance
Increase seen in age-adjusted drug overdose death rates involving methamphetamine, cocaine; decrease reported in death rates involving oxycodone
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
The U.S. Food and Drug Administration approved OTC Narcan nasal spray last month to be sold without a prescription
Conditioned open-label placebo had no impact on the 90-day methadone dose, but did improve sleep quality
Increases also seen for coprescribing with opioids